Bode John B Insider Trades

Insider Trading History

Track insider trading activity for Bode John B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $255k 19,600 shares
Last Trade
Mar 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717k 78,400 shares
$9.15
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $1.6M 123,400 shares
Last Trade
Mar 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717k 78,400 shares
$9.15
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $585k 45,000 shares
Last Trade
Aug 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$45.9k 5,000 shares
$9.17
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $390k 30,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 30,000 shares
$8.62
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $520k 40,000 shares
Last Trade
Mar 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$79.6k 10,000 shares
$7.96
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $390k 30,000 shares
Last Trade
Jul 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.7k 10,000 shares
$5.87
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $510k 39,200 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 39,200 shares
$4.89
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $260k 20,000 shares
Last Trade
Sep 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.3k 10,000 shares
$5.13
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Director
Holding Value $116k 20,000 shares
Last Trade
Sep 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.1k 10,000 shares
$5.81
$5.81
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $130k 10,000 shares
Last Trade
May 18, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.4k 10,000 shares
$5.04
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Director
Holding Value $58.1k 10,000 shares
Last Trade
May 18, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.1k 10,000 shares
$5.81
$5.81
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $764k 58,800 shares
Last Trade
May 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$292k 58,800 shares
$4.97
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Director
Holding Value $342k 58,800 shares
Last Trade
May 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$342k 58,800 shares
$5.81
$5.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up